Management of hepatocellular carcinoma in Japan: Consensus-Based Clinical Practice Guidelines proposed by the Japan Society of Hepatology (JSH) 2010 updated version. (Q51541140)

From Wikidata

Jump to navigation Jump to search

scientific article published on 9 August 2011

Language	Label	Description	Also known as
English	Management of hepatocellular carcinoma in Japan: Consensus-Based Clinical Practice Guidelines proposed by the Japan Society of Hepatology (JSH) 2010 updated version.	scientific article published on 9 August 2011

Statements

scholarly article

1 reference

Europe PubMed Central

6 April 2018

http://europepmc.org/abstract/MED/21829027

Management of hepatocellular carcinoma in Japan: Consensus-Based Clinical Practice Guidelines proposed by the Japan Society of Hepatology (JSH) 2010 updated version. (English)

1 reference

Europe PubMed Central

6 April 2018

http://europepmc.org/abstract/MED/21829027

hepatocellular carcinoma

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

object named as

Masatoshi Kudo

1

0 references

Masatoshi Makuuchi

8

object named as

Masatoshi Makuuchi

1 reference

Europe PubMed Central

6 April 2018

http://europepmc.org/abstract/MED/21829027

Norihiro Kokudo

3

object named as

Norihiro Kokudo

1 reference

Europe PubMed Central

6 April 2018

http://europepmc.org/abstract/MED/21829027

2

object named as

Namiki Izumi

1 reference

Europe PubMed Central

6 April 2018

http://europepmc.org/abstract/MED/21829027

Michiie Sakamoto

5

object named as

Michiie Sakamoto

1 reference

Europe PubMed Central

6 April 2018

http://europepmc.org/abstract/MED/21829027

Osamu Nakashima

6

object named as

Osamu Nakashima

1 reference

Europe PubMed Central

6 April 2018

http://europepmc.org/abstract/MED/21829027

Masamichi Kojiro

7

object named as

Masamichi Kojiro

1 reference

Europe PubMed Central

6 April 2018

http://europepmc.org/abstract/MED/21829027

author name string

Osamu Matsui

4

1 reference

Europe PubMed Central

6 April 2018

http://europepmc.org/abstract/MED/21829027

HCC Expert Panel of Japan Society of Hepatology

9

1 reference

Europe PubMed Central

6 April 2018

http://europepmc.org/abstract/MED/21829027

publication date

9 August 2011

1 reference

Europe PubMed Central

6 April 2018

http://europepmc.org/abstract/MED/21829027

Digestive Diseases

1 reference

Europe PubMed Central

6 April 2018

http://europepmc.org/abstract/MED/21829027

29

1 reference

Europe PubMed Central

6 April 2018

http://europepmc.org/abstract/MED/21829027

3

1 reference

Europe PubMed Central

6 April 2018

http://europepmc.org/abstract/MED/21829027

339-364

1 reference

Europe PubMed Central

6 April 2018

http://europepmc.org/abstract/MED/21829027

Management of hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1159%2F000327577

21 January 2018

Management of hepatocellular carcinoma: An update

1 reference

https://api.crossref.org/works/10.1159%2F000327577

21 January 2018

Guidelines for the treatment of chronic hepatitis and cirrhosis due to hepatitis B virus infection for the fiscal year 2008 in Japan

1 reference

https://api.crossref.org/works/10.1159%2F000327577

21 January 2018

Clinical practice guidelines for hepatocellular carcinoma: the first evidence based guidelines from Japan

1 reference

https://api.crossref.org/works/10.1159%2F000327577

21 January 2018

Dissemination of evidence-based clinical practice guidelines for hepatocellular carcinoma among Japanese hepatologists, liver surgeons and primary care physicians

1 reference

https://api.crossref.org/works/10.1159%2F000327577

21 January 2018

Management of hepatocellular carcinoma: Report of Consensus Meeting in the 45th Annual Meeting of the Japan Society of Hepatology (2009).

1 reference

https://api.crossref.org/works/10.1159%2F000327577

21 January 2018

Long-term beneficial effect of interferon therapy in patients with chronic hepatitis B virus infection

1 reference

https://api.crossref.org/works/10.1159%2F000327577

21 January 2018

Interferon therapy in HBeAg positive chronic hepatitis reduces progression to cirrhosis and hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1159%2F000327577

21 January 2018

Lamivudine for patients with chronic hepatitis B and advanced liver disease

1 reference

https://api.crossref.org/works/10.1159%2F000327577

21 January 2018

Outcome of hepatitis B e antigen-negative chronic hepatitis B on long-term nucleos(t)ide analog therapy starting with lamivudine

1 reference

https://api.crossref.org/works/10.1159%2F000327577

21 January 2018

Risk factors for hepatocellular carcinoma and its incidence after interferon treatment in patients with chronic hepatitis C. Osaka Liver Disease Study Group

1 reference

https://api.crossref.org/works/10.1159%2F000327577

21 January 2018

Hepatitis B e antigen and the risk of hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1159%2F000327577

21 January 2018

Effect of interferon alpha-2b plus ribavirin therapy on incidence of hepatocellular carcinoma in patients with chronic hepatitis

1 reference

https://api.crossref.org/works/10.1159%2F000327577

21 January 2018

Maintenance peginterferon therapy and other factors associated with hepatocellular carcinoma in patients with advanced hepatitis C

1 reference

https://api.crossref.org/works/10.1159%2F000327577

21 January 2018

Interferon therapy for 2 years or longer reduces the incidence of hepatocarcinogenesis in patients with chronic hepatitis C viral infection.

1 reference

https://api.crossref.org/works/10.1159%2F000327577

21 January 2018

A large-scale, multicentre, double-blind trial of ursodeoxycholic acid in patients with chronic hepatitis C

1 reference

https://api.crossref.org/works/10.1159%2F000327577

21 January 2018

Long-term phlebotomy with low-iron diet therapy lowers risk of development of hepatocellular carcinoma from chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1159%2F000327577

21 January 2018

Early stages of multistep hepatocarcinogenesis: adenomatous hyperplasia and early hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1159%2F000327577

21 January 2018

Interstitial tumour cell invasion in small hepatocellular carcinoma. Evaluation in microscopic and low magnification views.

1 reference

https://api.crossref.org/works/10.1159%2F000327577

21 January 2018

Pathologic diagnosis of early hepatocellular carcinoma: a report of the international consensus group for hepatocellular neoplasia

1 reference

https://api.crossref.org/works/10.1159%2F000327577

21 January 2018

Will Gd-EOB-MRI change the diagnostic algorithm in hepatocellular carcinoma?

1 reference

https://api.crossref.org/works/10.1159%2F000327577

21 January 2018

Atypical large well-differentiated hepatocellular carcinoma with benign nature: a new clinical entity

1 reference

https://api.crossref.org/works/10.1159%2F000327577

21 January 2018

Efficacy of double arterial phase dynamic magnetic resonance imaging with the sensitivity encoding technique versus dynamic multidetector-row helical computed tomography for detecting hypervascular hepatocellular carcinoma.

1 reference

https://api.crossref.org/works/10.1159%2F000327577

21 January 2018

Differential diagnosis of hepatic tumors: value of contrast-enhanced harmonic sonography using the newly developed contrast agent, Sonazoid.

1 reference

https://api.crossref.org/works/10.1159%2F000327577

21 January 2018

Abc protein transport of MRI contrast agents in canalicular rat liver plasma vesicles and yeast vacuoles.

1 reference

https://api.crossref.org/works/10.1159%2F000327577

21 January 2018

Expression of OATP1B3 determines uptake of Gd-EOB-DTPA in hepatocellular carcinoma.

1 reference

https://api.crossref.org/works/10.1159%2F000327577

21 January 2018

Hepatocellular carcinoma: signal intensity at gadoxetic acid-enhanced MR Imaging--correlation with molecular transporters and histopathologic features.

1 reference

https://api.crossref.org/works/10.1159%2F000327577

21 January 2018

The 2008 Okuda lecture: Management of hepatocellular carcinoma: from surveillance to molecular targeted therapy

1 reference

https://api.crossref.org/works/10.1159%2F000327577

21 January 2018

Progression to hypervascular hepatocellular carcinoma: correlation with intranodular blood supply evaluated with CT during intraarterial injection of contrast material

1 reference

https://api.crossref.org/works/10.1159%2F000327577

21 January 2018

Natural history of hepatocellular carcinoma and prognosis in relation to treatment. Study of 850 patients

1 reference

https://api.crossref.org/works/10.1159%2F000327577

21 January 2018

Prognosis of hepatocellular carcinoma: the BCLC staging classification

1 reference

https://api.crossref.org/works/10.1159%2F000327577

21 January 2018

Prognostic staging system for hepatocellular carcinoma (CLIP score): its value and limitations, and a proposal for a new staging system, the Japan Integrated Staging Score (JIS score).

1 reference

https://api.crossref.org/works/10.1159%2F000327577

21 January 2018

Proposal of a new prognostic model for hepatocellular carcinoma: an analysis of 403 patients

1 reference

https://api.crossref.org/works/10.1159%2F000327577

21 January 2018

Validation of a new prognostic staging system for hepatocellular carcinoma: a comparison of the biomarker-combined Japan Integrated Staging Score, the conventional Japan Integrated Staging Score and the BALAD Score

1 reference

https://api.crossref.org/works/10.1159%2F000327577

21 January 2018

Sorafenib in advanced hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1159%2F000327577

21 January 2018

Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1159%2F000327577

21 January 2018

Management of hepatocellular carcinoma in Japan: consensus-based clinical practice manual proposed by the Japan Society of Hepatology

1 reference

https://api.crossref.org/works/10.1159%2F000327577

21 January 2018

Newly Developed Novel Ultrasound Technique, Defect Reperfusion Ultrasound Imaging, Using Sonazoid in the Management of Hepatocellular Carcinoma

1 reference

https://api.crossref.org/works/10.1159%2F000327577

21 January 2018

Double-Contrast Ultrasound: A Novel Surveillance Tool for Hepatocellular Carcinoma

1 reference

https://api.crossref.org/works/10.1159%2F000327577

21 January 2018

Defect Reperfusion Imaging, a Newly Developed Novel Technology using Sonazoid in the Treatment of Hepatocellular Carcinoma

1 reference

https://api.crossref.org/works/10.1159%2F000327577

21 January 2018

Radiofrequency ablation guided by contrast harmonic sonography using perfluorocarbon microbubbles (Sonazoid) for hepatic malignancies: an initial experience

1 reference

https://api.crossref.org/works/10.1159%2F000327577

21 January 2018

Sonazoid-enhanced Ultrasound in the Diagnosis and Treatment of Hepatic Tumors

1 reference

https://api.crossref.org/works/10.1159%2F000327577

21 January 2018

Validation of a new prognostic staging system for hepatocellular carcinoma: The JIS score compared with the CLIP score

1 reference

https://api.crossref.org/works/10.1159%2F000327577

21 January 2018

Identifiers

10.1159/000327577

1 reference

Europe PubMed Central

6 April 2018

http://europepmc.org/abstract/MED/21829027

1 reference

Europe PubMed Central

6 April 2018

http://europepmc.org/abstract/MED/21829027

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q51541140&oldid=1873390182"